Paper15922945
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?
Sitkovsky MV and 1 other. Trends Immunol, 2005. Cited by 211 papers, by iCite.
Cite this record
ConductScience Library. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Papers, record 15922945. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15922945
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity | Major topic |
| Receptors, Adenosine A2 | Major topic |
| Adenosine | |
| Animals | |
| Humans | |
| Inflammation | |
| Time Factors |
Source PubMed
Cited by138
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 211 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42656532 | Chronic TLR7 activation promotes expansion of activated CD11c+ double-negative B cells and autoreactive humoral responses in lupus-like autoimmunity. | Front Immunol | 2026 | https://conductscience.org/library/papers/42656532 | PubMed |
| 42543247 | Adenosine Receptor 3 Antagonism Suppresses Adipogenesis via the EREG-EGFR-Leptin Axis in Multipotent Cells. | Biofactors | 2026 | https://conductscience.org/library/papers/42543247 | PubMed |
| 41596443 | Constitutively Active Stat5b Expression in Dendritic Cells Enhances Treg-Mediated Elimination of Autoreactive CD8+ T Cells in Autoimmune Diabetes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596443 | PubMed |
| 40303336 | Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy. | Theranostics | 2025 | https://conductscience.org/library/papers/40303336 | PubMed |
| 39329710 | Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects. | Cells | 2024 | https://conductscience.org/library/papers/39329710 | PubMed |
| 39072327 | Regulatory T cell homing and activation is a signature of neonatal sepsis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39072327 | PubMed |
| 38799466 | Glycan-based scaffolds and nanoparticles as drug delivery system in cancer therapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/38799466 | PubMed |
| 38500877 | Metabolic instruction of the graft-versus-leukemia immunity. | Front Immunol | 2024 | https://conductscience.org/library/papers/38500877 | PubMed |
| 38200005 | Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment. | Nat Commun | 2024 | https://conductscience.org/library/papers/38200005 | PubMed |
| 38039267 | Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni? | PLoS Negl Trop Dis | 2023 | https://conductscience.org/library/papers/38039267 | PubMed |
| 38018576 | Cell-based therapies for the treatment of rheumatoid arthritis. | Immun Inflamm Dis | 2023 | https://conductscience.org/library/papers/38018576 | PubMed |
| 37897562 | Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies. | Front Med | 2023 | https://conductscience.org/library/papers/37897562 | PubMed |
| 37892114 | The Role of Adenosine in γδ T-Cell Regulation of Th17 Responses in Experimental Autoimmune Uveitis. | Biomolecules | 2023 | https://conductscience.org/library/papers/37892114 | PubMed |
| 37891562 | Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade. | BMC Complement Med Ther | 2023 | https://conductscience.org/library/papers/37891562 | PubMed |
| 37843749 | Pharmacological interaction and immune response of purinergic receptors in therapeutic modulation. | Purinergic Signal | 2024 | https://conductscience.org/library/papers/37843749 | PubMed |
| 37576576 | Immune and inflammatory mechanism of remote ischemic conditioning: A narrative review. | Brain Circ | 2023 | https://conductscience.org/library/papers/37576576 | PubMed |
| 36267157 | Transforming growth factor-β in tumour development. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36267157 | PubMed |
| 36182536 | Schistosoma mansoni and the purinergic halo. | Trends Parasitol | 2022 | https://conductscience.org/library/papers/36182536 | PubMed |
| 35498376 | Remote Conditioning by Rhythmic Compression of Limbs Ameliorated Myocardial Infarction by Downregulation of Inflammation via A2 Adenosine Receptors. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/35498376 | PubMed |
| 34969052 | Schistosome immunomodulators. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/34969052 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15922945
GET https://conductscience.org/api/papers/v1/15922945/cited_by?page=2